You searched for lung cancer | Page 79 of 153

Biofidelity to Launch Enspyre Technology

Biofidelity is launching Enspyre, a novel target enrichment technology that significantly enhances NGS efficiency.

Posted by Chris Wolski | Jan 15, 2025 | Miscellaneous |

Following a People-to-People trip to Cuba, CLP Chief Editor Chris Wolski gained a more nuanced view of the Cuban healthcare system.

While serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.

Biofidelity’s test delivers comprehensive genomic profiling for NSCLC patients from tissue or liquid biopsy samples within two days.

Roche and Sheba Medical Center’s ARC are collaborating to enhance NSCLC diagnosis and treatment using AI-driven digital pathology tools.